Scotiabank analyst Nick Altmann downgrades Confluent (NASDAQ:CFLT) from Sector Outperform to Sector Perform and announces $21 price target.
Calliditas Therapeutics Announces That The U.S. Patent And Trademark Office Issued Patent #11896719, Entitled “New Pharmaceutical Compositions,” On January 24, 2024 With Validity As Of Today, February 13, 2024
Calliditas Therapeutics AB (NASDAQ:CALT, Nasdaq Stockholm: CALTX))) ("Calliditas") today announced that the United States Patent and Trademark Office (USPTO) issued patent no. 11896719, entitled "New Pharmaceutical
